Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Pharmaceutical (Nihon Seiyaku) is a specialized Japanese pharmaceutical company that focuses on the development and manufacture of plasma-derived products and gastrointestinal treatments. As a subsidiary of Takeda Pharmaceutical Company, it plays a critical role in the production of essential blood products and ethical drugs for the Japanese market. The company's portfolio includes treatments for digestive system diseases, nutritional supplements, and various plasma-based therapies. With a long history in the Japanese healthcare sector, it maintains significant manufacturing capabilities and a robust distribution network within the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japanese Pharmaceutical.